AB063. Potential synergistic effect by combination of PED-4 and PED-5 inhibitors plus theophylline in lung cancer?

BACKGROUND: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have be...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Transl Med
Main Authors: Domvri, Kalliopi, Hohenforst-Schmidt, Wolfgang, Zogas, Nikolaos, Petanidis, Savvas, Zarogoulidis, Paul, Porpodis, Konstantinos, Kioseoglou, Efi, Zarogoulidis, Konstantinos
格式: Artigo
語言:Inglês
出版: AME Publishing Company 2016
主題:
Abstract
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159351/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB063
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍